Immunosuppression for Myelodysplastic Syndrome: How Bench to Bedside to Bench Research Led to Success

Laboratory evidence and clinical evidence suggest that some patients with myelodysplastic syndrome (MDS) have immunologically mediated disease. This article describes the laboratory evidence supporting a role for the immune system in the marrow failure of MDS and clinical trials using IST in these patients.